期刊文献+

乳腺癌组织NRF-1表达及其意义的探讨

Significance of expression of NRF-1 protein in breast carcinoma tissues
原文传递
导出
摘要 目的:探讨乳腺癌组织中核呼吸因子-1(NRF-1)蛋白表达与乳腺癌发生、发展及临床病理特征的关系。方法:采用免疫组化EnVision二步法,对211例乳腺癌组织和50例乳腺良性病变组织中NRF-1蛋白表达进行检测。结果:NRF-1蛋白表达定位于细胞核,着色呈棕黄色,乳腺癌中阳性表达(82.7%)低于乳腺良性病变组织阳性表达(100%),χ2=100.288,P=0.000;高分化乳腺癌NRF-1阳性率明显高于中、低分化乳腺癌(χ2=16.242,P=0.001;χ2=72.802,P=0.000),中分化乳腺癌也明显高于低分化乳腺癌,χ2=30.190,P=0.000。乳腺癌淋巴结转移患者NRF-1蛋白阳性表达率明显低于未转移者,χ2=12.025,P=0.007;TNM分期中I期NRF-1蛋白阳性表达率明显高于Ⅱ、Ⅲ期,χ2=12.025,P=0.007。结论:NRF-1蛋白的表达可能与乳腺癌的发生发展密切相关,可作为乳腺癌患者疾病进展监控和预后观测的指标,具有临床应用价值。 OBJECTIVE: To study the relationship between the expression of NRF-1 protein and carcinogenesis,invasion,metastasis of the breast carcinoma.METHODS: NRF-1 protein expression in 211 cases of breast carcinoma and 50 cases benign lesion of the mammary gland was examined by immunohistochemical method.RESULTS: The NRF-1 protein located in nucleus.The positive rate of NRF-1 protein expression was 82.7% in breast carcinoma,and that was 100% in benign lesion of the mammary gland(χ2=100.288,P=0.000).Expression rates of NRF-1 protein in the well-differentiated of breast carcinoma were significantly than mid-differentiated and low-differentiated of breast carcinoma(χ2=16.242,P=0.001;χ2=72.802,P=0.000),and mid-differentiated higher than low-differentiated of breast carcinoma(χ2=30.190,P=0.000).Low or negative NRF-1 protein expression was associated with positive lymph node metastasis in breast carcinoma(χ2=12.025,P=0.007).The positive rate of NRF-1 protein was significantly lower in TNM Ⅱ,Ⅲ stage than TNM I stage(χ2=12.025,P=0.007).CONCLUSION: NRF-1 protein expression may be correlated to the occurrence and development of breast carcinoma,and can be a marker in the progression and prognosis of breast carcinoma.
出处 《中华肿瘤防治杂志》 CAS 2011年第14期1092-1095,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 济南军区总医院2010年度院长基金资助(2010Q01)
关键词 乳腺肿瘤 核呼吸因子-1 免疫组织化学 breast neoplasms NRF-1 immunohistochemistry
  • 相关文献

参考文献17

  • 1Dang C, Semenza G. Oncogenie alterations of metabolism[J]. Trends Bio Sci, 1999, 24(2) :68-72.
  • 2Carew J S, Huang P. Mitoehondriai defects in cancer[J]. Mol Cancer Dec, 2002, 9(1) :9-13.
  • 3Morrish F, Giedt C, Hockenbery D. C-myc apoptotic function is mediated by NRF-1 target genes [J]. Genes & development, 2003, 17(2) :240-255.
  • 4Fu J, Zhang J, Jin F, et al. Promoter regulation of the visinin- like subfamily of neuronal ealeium sensor proteins by nuclear respiratory factor-1 [J]. J Bio Chem, 2009, 284 (40):27577- 27586.
  • 5Beesley M F, Mclaren K M. Cytokeratin 19 and galectin-3 im- munohistochemistry in differential diagnosis of solitary thyroid nodules[J]. Histopathology, 2002, 41(3) : 236-243.
  • 6Derouin F, Caroff B, Chau F, et al. Synergistic activity of clar- ithromycin and minocycline in an animal model of acute experi- mental toxoplasmosis[J]. Antimicrob Agents Chemother, 1992, 36(12) :2852-2855.
  • 7Gugneja S, Scarpulla R C. Serine phosphorylation within a con cise amino-terminal domain in nuclear respiratory factor 1 en hances DNA binding[J]. J Biol Chemistry, 1997, 272 (30) 18732-18739.
  • 8Gugneja S, Virbasius C M, Scarpulla R C. Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hy- drophobic residues to activate transcription[J]. Mol Cell Biol, 1996,16(10) :5708-5716.
  • 9Chen L, Kwong M, Lu R, et al. Nrfl is critical for redox bal- ance and survival of liver cells during development[J]. Mol Cell Biol, 2003, 23(13):4673-4686.
  • 10Savagner F, Mirebeau D, Jacques C, et al. PGC-l-related coac- tivator and targets are upregulated in thyroid oncocytoma[J]. Biochemi Biophys Res Commun, 2003,310(3) : 779- 784.

二级参考文献24

  • 1张文敏,黄纲雄,黄爱民,高凌云,高美钦,陈碧芬.uPA和PAI-1在人脑胶质瘤的表达及其与肿瘤血管生成的关系[J].解剖学研究,2005,27(1):15-18. 被引量:2
  • 2刘运江,刘现义,刘巍,单保恩.hMAM检测乳腺癌骨髓微转移及其意义[J].中国肿瘤临床,2006,33(10):549-551. 被引量:5
  • 3:iotta i. A. Tumor invasion and metastases role of the extracel hdar matrix: Rhoads Memorial Award lecture[J]. Cancer Res, 1986, 46(1):1-7.
  • 4Ellenrieder V, Adeler G, Gress T M, et al. Invasion and metastasis in pancreatic cancer[J]. Ann Oncol, 1999. 10(Suppl 1): 46-50.
  • 5Gandolfo G M, Conyi L, Vercillo M, et al. Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma[J]. Anticancer Res, 1996, 16(4B): 2155-2161.
  • 6Liu G, Shuman M A, Cohen R L, et al. Co expression ofurokinase, urokinase receptor and Pal-1 is necessary for optimum invasivenessof cultured lung cancer cells[J]. Int J Cancer, 1995. 60(4):501-506.
  • 7Vohn M, Mattem J, Koomagi R. Relationship of urokinase and urokinase receptor in non small cell lung cancer to proliferation, angiogenesis, metastasis and patients survival[J]. Oncol Rep. 1999. 6(3):611-615.
  • 8Stephan B, Florian D, Bjqrn N, et al. A pooled analysis of bone marrow micrometastasis in breast cancer[J]. N Engl J Med, 2005, 353(8): 793-802.
  • 9Gottfried K, Michael U. Astrid P, et al. Association of urokinase type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer[J]. Clinical Cancer Res, 2001, 6(7):1743-1749.
  • 10Schmitt M, Harbeck N, Thomssen C, et al. Clinical impact of the plasminogen activation system in tumor ivasion and metastasis: prognostic relevance and target for lherapy [J]. Thromb Haemost, 1997, 78(1): 285-296.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部